Bharat Biotech's Covaxin is based on a whole inactivated virus platform, an old technology which is used to make vaccines given to infants
from Latest News https://ift.tt/2Mult6e
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd
Home
Business
Business News
Business Standard
Latest News
Controversy around Bharat Biotech's Covaxin approval without efficacy data
Monday, January 4, 2021
Related Posts:
‘Big Four’ accountancy giants face UK probeThe powerful companies engage in a wide range of activities, from acco… Read More
Reduced pressure from crude, rupee prompts FMCG firms to defer price hikesEase in inflation amid drop in oil prices has prompted firms to defer … Read More
'Note ban, GST cost economy Rs 4.8 lakh crore'As a result of the faulty implementation of GST, the states earned Rs … Read More
Mindtree focusing on IP-driven growth as traditional legacy biz slows downThe move comes at a time when the traditional software maintenance and… Read More
0 comments: